EB-1B Dismissed — Pharmaceutical Sciences (2022): did not establish the beneficiary is internationally

Decision Summary

The appeal was dismissed because the petitioner failed to establish that the beneficiary is internationally recognized as outstanding in her academic field. Although the beneficiary met three initial evidentiary criteria, the AAO determined in its final merits review that the evidence in totality, including citation records and expert letters, was insufficient to prove her work was considered outstanding by others in her field.

Criteria Discussed

Sign up free to download the original PDF